State of Michigan Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5M Buy
+82,547
New +$4.35M 0.02% 481
2021
Q4
– Sell
-32,386
Closed -$3.63M – 980
2021
Q3
$3.63M Hold
32,386
– – 0.02% 468
2021
Q2
$5.24M Hold
32,386
– – 0.03% 397
2021
Q1
$3.95M Hold
32,386
– – 0.03% 468
2020
Q4
$4.96M Sell
32,386
-11,010
-25% -$1.3M 0.03% 371
2020
Q3
$3.63M Buy
+43,396
New +$3.85M 0.03% 404

Other funds holding CRSP

State of Michigan Retirement System's CRSP Position: Q2 2026 in Review

State of Michigan Retirement System opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 82,547 shares worth $4.5M. The stake represents 0.02% of the portfolio and ranks #481 among its holdings. This is a return to the name: State of Michigan Retirement System previously reported a position in CRSP as recently as Q3 2021.

State of Michigan Retirement System first reported a position in CRSP in Q3 2020 and has held it in 6 quarters since. The position peaked at $5.24M in Q2 2021. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • State of Michigan Retirement System held 82,547 shares of CRISPR Therapeutics worth $4.5M as of Q2 2026.
  • CRISPR Therapeutics was a new State of Michigan Retirement System position in Q2 2026.
  • CRISPR Therapeutics made up 0.02% of State of Michigan Retirement System's portfolio in Q2 2026, its #481 holding.
  • State of Michigan Retirement System first reported a position in CRISPR Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • State of Michigan Retirement System's CRISPR Therapeutics position peaked at $5.24M in Q2 2021.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on State of Michigan Retirement System's 13F filing for Q2 2026, filed 30 Jul 2026.